/****** Font Awesome ******/ /****** Collapsing Nested Menu Items | Code by Elegant Themes ******/

Overview Services

Given the different pressures on pharmaceutical and biotech companies, we will be your strategic partner in vaccine development. Our scientists, with a wealth vaccine development experience, understand your challenges and can work with you to provide effective solutions. They also help you make robust and reliable interpretations and predictions from the preclinical studies.

Artemis uses a proprietary approach to analyse immunogenicity data

 

 

    • RECOMBINANT PROTEIN EXPRESSION SYSTEMS
      • Leishmania
      • Prokaryotic cells
      • Mammalian cells

    FIND OUT MORE

 

 

  • Quantitative PCR
  • ELISA and other serological assays

  Find out more

TARGET VIRUSES

  • Arboviruses (Dengue virus, West Nile virus, Japanese encephalitis virus, Tick-borne encephalitis virus, Yellow fever virus, Zika virus, Chikungunya virus, Ross river virus)
  • Zoonotic viruses (rabies virus, influenza virus, Middle-East respiratory syndrome MERS coronavirus)
  • Respiratory viruses (respiratory syncytial virus, influenza virus, human metapneumovirus)
  • Herpes viruses (cytomegalovirus, Epstein-Barr virus)

FIND OUT MORE

ANIMAL MODELS

  • Mouse models
  • Rat models (including cotton rats)
  • Rabbit model
  • Ferret model
  • Non-human primate models

 

FIND OUT MORE

 

  • ANTIVIRAL & VACCINE RESEARCH 
    • Study design and planning
    • Study management
    • Data management
    • Biostatistics
  • SCIENTIFIC CONSULTATION
    • Results interpretation
    • Medical writing and preparation of scientific manuscripts
    • Biomedical grant application

 

FIND OUT MORE

Artemis uses a proprietary approach to analyse immunogenicity data

 

 

    • RECOMBINANT PROTEIN EXPRESSION SYSTEMS
      • Leishmania
      • Prokaryotic cells
      • Mammalian cells

    FIND OUT MORE

 

 

  • Quantitative PCR
  • ELISA and other serological assays

 

Find out more

TARGET VIRUSES

  • Arboviruses (Dengue virus, West Nile virus, Japanese encephalitis virus, Tick-borne encephalitis virus, Yellow fever virus, Zika virus, Chikungunya virus, Ross river virus)
  • Zoonotic viruses (rabies virus, influenza virus, Middle-East respiratory syndrome MERS coronavirus)
  • Respiratory viruses (respiratory syncytial virus, influenza virus, human metapneumovirus)
  • Herpes viruses (cytomegalovirus, Epstein-Barr virus)

FIND OUT MORE

ANIMAL MODELS

  • Mouse models
  • Rat models (including cotton rats)
  • Rabbit model
  • Ferret model
  • Non-human primate models

 

FIND OUT MORE

 

  • ANTIVIRAL & VACCINE RESEARCH 
    • Study design and planning
    • Study management
    • Data management
    • Biostatistics
  • SCIENTIFIC CONSULTATION
    • Results interpretation
    • Medical writing and preparation of scientific manuscripts
    • Biomedical grant application

 

FIND OUT MORE

Results Interpretation:

All of the information gathered in the exploratory, preclinical process must be pulled together in the interpretation of the data. The task of interpreting immunogenicity and efficacy data requires a broad range of skills and knowledge that must tie information at the scale of safety and protective efficacy in the end host. The data generated during the exploratory preclinical process will be managed at Artemis Bio-Support and analyzed based on the latest biostatistics and modeling approaches.

BSL-2 and BSL-3 FACILITIES

Artemis has access to BSL-2 and BSL-3 laboratory and animal facilities, with an extensive collaborative network to conduct high-containment studies, and dedicated personnel to position ourselves as your independent advisor and partner in vaccine and antiviral evaluation.

ARTEMIS BIO-SUPPORT

Artemis Bio-support is a Contract Research Organization (CRO) specialized in the evaluation of viral vaccines and antiviral therapeutics.

 

CONTACT US

Molengraaffsingel 10
2629 JD Delft
The Netherlands

+31 (0) 30 635 5444

info@artemis-biosupport.com

Mo-Fri: 9:00 AM - 7:00 PM (local time)

Chamber of Commerce number: 51502259